1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Orphan Drugs Market, By Disease Type
5.1 Introduction
5.2 Oncological Diseases
5.2.1 Pancreatic Cancer
5.2.2 Acute Myeloid Leukemia
5.2.3 Multiple Myeloma
5.2.4 Ovarian Cancer
5.2.5 Renal Cell Carcinoma
5.3 Metabolic Diseases
5.3.1 Hunter Syndrome
5.3.2 Gaucher Disease
5.3.3 Fabry Disease
5.3.4 Hypoparathyroidism
5.4 Hematologic & Immunologic Diseases
5.4.1 Hemophilia
5.4.2 Hereditary Angioedema
5.5 Infectious diseases
5.6 Neurological diseases
5.6.1 Huntington’s Disease
5.6.2 Alzheimer’s Disease
6 Global Orphan Drugs Market, By Drug Type
6.1 Introduction
6.2 Non-Biologics
6.3 Biologics
7 Global Orphan Drugs Market, By Sale
7.1 Introduction
7.2 Prescribed
7.3 Generics
8 Global Orphan Drugs Market, By Drug
8.1 Introduction
8.2 Rituxan
8.3 Revlimid
8.4 Imbruvica
8.5 Opdivo
8.6 Darzalex
8.7 Pomalyst
8.8 Other Drugs
9 Global Orphan Drugs Market, By Distribution Channel
9.1 Introduction
9.2 Online Pharmacies
9.3 Hospital Pharmacies
9.4 Retail Pharmacies
9.5 Other Distribution Channels
10 Global Orphan Drugs Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Bayer AG
12.2 Novartis AG
12.3 F. Hoffmann-La Roche Ltd
12.4 Bristol-Myers Squibb Company
12.5 Amgen Inc.
12.6 Novo Nordisk A/S
12.7 Alexion Pharmaceuticals Inc.
12.8 GlaxoSmithKline plc
12.9 AstraZeneca
12.10 Celgene Corporation
12.11 Mylan
12.12 Biogen
12.13 Merck KGaA
12.14 Takeda Pharmaceutical Company Limited
12.15 Eli Lilly and Company
12.16 Shire Pharmaceutical
List of Tables
Table 1 Global Orphan Drugs Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Orphan Drugs Market Outlook, By Disease Type (2021-2030) ($MN)
Table 3 Global Orphan Drugs Market Outlook, By Oncological Diseases (2021-2030) ($MN)
Table 4 Global Orphan Drugs Market Outlook, By Pancreatic Cancer (2021-2030) ($MN)
Table 5 Global Orphan Drugs Market Outlook, By Acute Myeloid Leukemia (2021-2030) ($MN)
Table 6 Global Orphan Drugs Market Outlook, By Multiple Myeloma (2021-2030) ($MN)
Table 7 Global Orphan Drugs Market Outlook, By Ovarian Cancer (2021-2030) ($MN)
Table 8 Global Orphan Drugs Market Outlook, By Renal Cell Carcinoma (2021-2030) ($MN)
Table 9 Global Orphan Drugs Market Outlook, By Metabolic Diseases (2021-2030) ($MN)
Table 10 Global Orphan Drugs Market Outlook, By Hunter Syndrome (2021-2030) ($MN)
Table 11 Global Orphan Drugs Market Outlook, By Gaucher Disease (2021-2030) ($MN)
Table 12 Global Orphan Drugs Market Outlook, By Fabry Disease (2021-2030) ($MN)
Table 13 Global Orphan Drugs Market Outlook, By Hypoparathyroidism (2021-2030) ($MN)
Table 14 Global Orphan Drugs Market Outlook, By Hematologic & Immunologic Diseases (2021-2030) ($MN)
Table 15 Global Orphan Drugs Market Outlook, By Hemophilia (2021-2030) ($MN)
Table 16 Global Orphan Drugs Market Outlook, By Hereditary Angioedema (2021-2030) ($MN)
Table 17 Global Orphan Drugs Market Outlook, By Infectious diseases (2021-2030) ($MN)
Table 18 Global Orphan Drugs Market Outlook, By Neurological diseases (2021-2030) ($MN)
Table 19 Global Orphan Drugs Market Outlook, By Huntington’s Disease (2021-2030) ($MN)
Table 20 Global Orphan Drugs Market Outlook, By Alzheimer’s Disease (2021-2030) ($MN)
Table 21 Global Orphan Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
Table 22 Global Orphan Drugs Market Outlook, By Non-Biologics (2021-2030) ($MN)
Table 23 Global Orphan Drugs Market Outlook, By Biologics (2021-2030) ($MN)
Table 24 Global Orphan Drugs Market Outlook, By Sale (2021-2030) ($MN)
Table 25 Global Orphan Drugs Market Outlook, By Prescribed (2021-2030) ($MN)
Table 26 Global Orphan Drugs Market Outlook, By Generics (2021-2030) ($MN)
Table 27 Global Orphan Drugs Market Outlook, By Drug (2021-2030) ($MN)
Table 28 Global Orphan Drugs Market Outlook, By Rituxan (2021-2030) ($MN)
Table 29 Global Orphan Drugs Market Outlook, By Revlimid (2021-2030) ($MN)
Table 30 Global Orphan Drugs Market Outlook, By Imbruvica (2021-2030) ($MN)
Table 31 Global Orphan Drugs Market Outlook, By Opdivo (2021-2030) ($MN)
Table 32 Global Orphan Drugs Market Outlook, By Darzalex (2021-2030) ($MN)
Table 33 Global Orphan Drugs Market Outlook, By Pomalyst (2021-2030) ($MN)
Table 34 Global Orphan Drugs Market Outlook, By Other Drugs (2021-2030) ($MN)
Table 35 Global Orphan Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 36 Global Orphan Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
Table 37 Global Orphan Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 38 Global Orphan Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
Table 39 Global Orphan Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
